Inicio > BERNARDO ORDIZ, DAVID

BERNARDO ORDIZ, DAVID

[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80454]], camposKey:1661-6596 2023-09-01 Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76153]], camposKey:1460-2725 2023-03-27 MIF is a common genetic determinant of COVID-19 symptomatic infection and severity205212, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80963]], camposKey:1664-3224 2023-01-01 Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80964]], camposKey:2218-6751 2023-01-01 Top-of-The-Art cytometry as a novel tool to aid in lung cancer immunotherapy957961, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76155]], camposKey:2045-2322 2022-12-01 Metabolomics study of COVID-19 patients in four different clinical stages00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76154]], camposKey:2041-1723 2022-12-01 Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76099]], camposKey:0964-6906 2022-11-10 Novel genes and sex differences in COVID-19 severity37893806, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74160]], camposKey:1661-6596 2022-10-01 Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76156]], camposKey:0028-0836 2022-08-04 A first update on mapping the human genetic architecture of COVID-1900, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76157]], camposKey:2227-9059 2022-08-01 Differential Effects of Anti-TNF¿ and Anti-¿4ß7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel Disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74161]], camposKey:0028-0836 2022-07-07 Whole-genome sequencing reveals host factors underlying critical COVID-1997103, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77009]], camposKey:1873-9946 2022-01-01 Effects of anti-TNF and anti-alpha 4 beta 7 drugs on circulating monocytes migratory capacity in inflammatory bowel disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71441]], camposKey:1873-9946 2022-01-01 Human intestinal CD103+SIRP alpha plus conventional dendritic cells from patients with Crohn's disease prime IL-17+T-cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65608]], camposKey:0028-0836 2021-12-16 Mapping the human genetic architecture of COVID-19472477, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64892]], camposKey:0021-9738 2021-12-01 Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74162]], camposKey:2211-1247 2021-11-16 SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65938]], camposKey:1664-3224 2021-10-13 Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74163]], camposKey:2075-4426 2021-07-01 Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59984]], camposKey:1613-4125 2021-06-01 Lunasin Peptide is a Modulator of the Immune Response in the Human Gastrointestinal Tract00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=83203]], camposKey:2077-0383 2021-05-01 HGF, IL-1¿, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74164]], camposKey:2227-9059 2021-04-01 Growth arrest-specific factor 6 (Gas6) is increased in covid-19 patients and predicts clinical outcome00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77010]], camposKey:2045-2322 2021-03-29 Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59985]], camposKey:1078-0998 2021-02-01 Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates between Type and Mucosal Status in Patients with Inflammatory Bowel Disease268274, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64891]], camposKey:0014-2980 2021-01-01 Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)27083145, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66422]], camposKey:1937-6448 2021-01-01 Human intestinal dendritic cell and macrophage subsets in coeliac disease85104, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77011]], camposKey:2045-2322 2020-10-22 Serum adipokines as non-invasive biomarkers in Crohn's disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59986]], camposKey:0167-7012 2020-10-01 A quick flow cytometry protocol to assess Helicobacter pylori viability00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59987]], camposKey:0954-691X 2020-05-01 Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease588596, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52746]], camposKey:1613-4125 2020-01-01 Circulating Dendritic Cells from Celiac Disease Patients Display a Gut-Homing Profile and are Differentially Modulated by Different Gliadin-Derived Peptides00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52747]], camposKey:1078-0998 2020-01-01 Different Intraepithelial CD3+ Cell Numbers in Crohn's Disease and Ulcerative Colitis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52761]], camposKey:1130-0108 2020-01-01 Duodenal lymphogram as a complementary tool in the diagnosis of celiac disease in adults00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77012]], camposKey:1873-9946 2020-01-01 Identification of constitutive modifications in plasma cells and B lymphocytes in patients with inflammatory bowel disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52748]], camposKey:1130-0108 2020-01-01 Is celiac disease really associated with inflammatory bowel disease?46, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77014]], camposKey:1873-9946 2020-01-01 Profiling of human circulating dendritic cells and monocytes subsets discriminates type and mucosal status in patients with inflammatory bowel disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77015]], camposKey:1873-9946 2020-01-01 Proteomic characterisation of serum extracellular vesicles in patients with inflammatory bowel diseases: a novel approach for biomarker discovery00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77013]], camposKey:1873-9946 2020-01-01 Serum adipokines as non-invasive biomarker in Crohn's disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77016]], camposKey:1873-9946 2019-03-01 Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49117]], camposKey:1756-283X 2019-01-01 Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52767]], camposKey:1873-9946 2019-01-01 CD103+SIRP alpha plus DC are specifically decreased in the inflamed colon from patients with ulcerative colitis but not with Crohn's disease1130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49111]], camposKey:1746-0441 2019-01-01 Challenges to drug discovery for celiac disease and approaches to overcome them957968, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49113]], camposKey:0163-2116 2019-01-01 Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients846854, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49115]], camposKey:0269-2813 2019-01-01 Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU419428, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52749]], camposKey:1873-9946 2019-01-01 Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease13801386, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49417]], camposKey:1756-283X 2019-01-01 Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52750]], camposKey:2072-6643 2019-01-01 Immunomodulatory effect of gut microbiota-derived bioactive peptides on human immune system from healthy controls and patients with inflammatory bowel disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49114]], camposKey:1074-7613 2019-01-01 Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52765]], camposKey:1873-9946 2019-01-01 Novel immunomodulatory role of food bioactive peptide lunasin in the healthy human intestinal mucosa9293, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49116]], camposKey:1756-4646 2019-01-01 Peptides encrypted in the human intestinal microbial-exoproteome as novel biomarkers and immunomodulatory compounds in the gastrointestinal tract459468, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49112]], camposKey:0924-2244 2019-01-01 Role of food proteins and bioactive peptides in inflammatory bowel disease194206, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77017]], camposKey:1083-4389 2018-09-01 A quick flow cytometry protocol to assess Helicobacter pylori viability and density00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77018]], camposKey:1873-9946 2018-02-01 Bifidobacterium longum subsp longum microbiota-secreted bioactive peptide as a novel immunomodulatory compound in the human gastrointestinal tract00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77019]], camposKey:1873-9946 2018-02-01 Human intestinal pro-inflammatory CD11c(high) macrophages, but not their transient CD11c(dim) or tolerogenic CD11c-counterparts, are expanded in inflammatory bowel disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49120]], camposKey:1873-9946 2018-01-01 CD16+ macrophages mediate fibrosis in inflammatory bowel disease589599, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49121]], camposKey:1613-4125 2018-01-01 Human Intestinal Dendritic Cells in Inflammatory Bowel Diseases00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49119]], camposKey:1933-0219 2018-01-01 Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel disease article11141126, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49118]], camposKey:1078-0998 2018-01-01 The Innate Immune System in the Gastrointestinal Tract: Role of Intraepithelial Lymphocytes and Lamina Propria Innate Lymphoid Cells in Intestinal Inflammation16491659, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52751]], camposKey:2155-384X 2018-01-01 Toll-like receptors-mediated pathways activate inflammatory responses in the esophageal mucosa of adult eosinophilic esophagitis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77020]], camposKey:1873-9946 2017-02-01 Characterization of human intestinal macrophage subsets in health and inflammatory bowel disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52771]], camposKey:0017-5749 2017-01-01 Differential immune responses between proximal and distal colorectal cancer00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77025]], camposKey:0815-9319 2016-10-01 Altered tissue homing and cytokine production in dendritic cells and monocytes in Crohn's disease121121, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77024]], camposKey:0815-9319 2016-10-01 Vitamin D regulates dendritic cell activity and trafficking in Crohn's disease121122, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77022]], camposKey:0016-5085 2016-04-01 Aberrant Circulating Dendritic Cell Cytokine Production and Homing Profile in Crohn's Disease is Normalised by Anti-TNF-alpha Therapy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77023]], camposKey:0016-5085 2016-04-01 Risk Factors Associated With the Negativization of Anti-HBs Antibodies in Inflammatory Bowel Disease Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77021]], camposKey:0016-5085 2016-04-01 TNF-Alpha Activity in Plasma From Patients With Inflammatory Bowel Disease Under Adalimumab and Infliximab Treatment Evaluated in a Cell-Based Assay00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77029]], camposKey:1873-9946 2016-03-01 Anti-TNF-alpha therapy normalises aberrant cytokine production and homing profile of circulating dendritic cells in Crohn's disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77028]], camposKey:1873-9946 2016-03-01 Characterisation of human intestinal dendritic cells and macrophages through the lower gastrointestinal tract00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77026]], camposKey:1873-9946 2016-03-01 Risk factors associated with the negativisation of anti-HBs antibodies in inflammatory bowel disease patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77027]], camposKey:1873-9946 2016-03-01 TNF-alpha activity in plasma from patients with inflammatory bowel disease under adalimumab and infliximab treatment evaluated in a cell-based assay00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52752]], camposKey:1949-2553 2016-01-01 Age-related alterations in blood and colonic dendritic cell properties1191311922, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49122]], camposKey:1010-4283 2016-01-01 Body composition of the host influences dendritic cell phenotype in patients treated for colorectal cancer1135911364, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52756]], camposKey:2352-345X 2016-01-01 Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal Colon2239, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49123]], camposKey:0017-5749 2016-01-01 Compartment-specific immunity in the human gut: Properties and functions of dendritic cells in the colon versus the ileum256270, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3282]], camposKey:1756-4646 2016-01-01 Differential immunomodulatory effects of Lactobacillus rhamnosus DR20, Lactobacillus fermentum CECT 5716 and Bifidobacterium animalis subsp. lactis on monocyte-derived dendritic cells300312, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49419]], camposKey:1654-6628 2016-01-01 Identification and molecular characterization of oat peptides implicated on coeliac immune response00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49418]], camposKey:1522-8037 2016-01-01 Immunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3284]], camposKey:2234-943X 2015-01-01 Human colon-derived soluble factors modulate gut microbiota composition00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=5725]], camposKey:2072-6643 2015-01-01 Increased intraepithelial V alpha24 invariant NKT cells in the celiac duodenum.89608976, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49125]], camposKey:2314-8861 2015-01-01 Intestinal microbiota as modulators of the immune system00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49124]], camposKey:0748-7983 2015-01-01 Is right-sided colon cancer different to left-sided colorectal cancer? - A systematic review300308, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49420]], camposKey:1541-9061 2015-01-01 Prognostic value of the tumour-infiltrating dendritic cells in colorectal cancer: A systematic review914, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59988]], camposKey:2314-6133 2015-01-01 Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: A multicenter study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49126]], camposKey:0022-4790 2015-01-01 The prognostic significance and relationship with body composition of CCR7-positive cells in colorectal cancer8692, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52753]], camposKey:2045-2322 2015-01-01 Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2872]], camposKey:1613-4125 2014-01-01 Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp11321143, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49128]], camposKey:1130-0108 2014-01-01 Coeliac disease in the oral mucosa? ¿Enfermedad celiaca en la mucosa oral?7376, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49130]], camposKey:1130-0108 2014-01-01 Constitutive gut-homing capacity on circulating myeloid dendritic cells in coeliac disease Capacidad constitutiva del intestino para células dendríticas mieloides circulantes en la enfermedad celiaca6465, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49129]], camposKey:0378-1097 2014-01-01 Extracellular molecular effectors mediating probiotic attributes111, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49132]], camposKey:1078-0998 2014-01-01 Human gut dendritic cells drive aberrant gut-specific T-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFN¿22992307, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49131]], camposKey:1078-0998 2014-01-01 Innate immune factors in the development and maintenance of pouchitis19421949, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2823]], camposKey:1130-0108 2014-01-01 Innate lymphoid cells and natural killer T cells in the immune system of the gastrointestinal tract334345, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49127]], camposKey:1568-0096 2014-01-01 The role of CD40 expression in dendritic cells in cancer biology; a systematic review610620, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77030]], camposKey:0019-2805 2013-12-01 Compartment specific tolerance and immunity in the human gut; properties and functions of dendritic cells and macrophages in the colon versus the ileum169169, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49136]], camposKey:1933-0219 2013-01-01 A mechanistic role for leptin in human dendritic cell migration: Differences between ileum and colon in health and Crohn's disease751761, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2866]], camposKey:1932-6203 2013-01-01 Detection of Specific IgA Antibodies against a Novel Deamidated 8-Mer Gliadin Peptide in Blood Plasma Samples from Celiac Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49135]], camposKey:0962-9351 2013-01-01 Dysregulated circulating dendritic cell function in ulcerative colitis is partially restored by probiotic strain lactobacillus casei shirota00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49140]], camposKey:1873-9946 2013-01-01 Homing marker expression on circulating dendritic cells correlates with different phenotypes of Crohn's disease594596, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49139]], camposKey:1130-0108 2013-01-01 Human intestinal dendritic cells as controllers of mucosal immunity279290, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49133]], camposKey:1873-9946 2013-01-01 Infliximab induces a dysregulated tissue-homing profile on human T-lymphocytes in-vitro: A novel mechanism for paradoxical inflammation?765767, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49138]], camposKey:0165-2478 2013-01-01 Intestinal dendritic cells: Their role in intestinal inflammation, manipulation by the gut microbiota and differences between mice and men3040, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49134]], camposKey:0009-9104 2013-01-01 Lost therapeutic potential of monocyte-derived dendritic cells through lost tissue homing: Stable restoration of gut specificity with retinoic acid109119, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49137]], camposKey:1078-0998 2013-01-01 Mechanisms of action of anti-tumor necrosis factor alpha agents in Crohn's disease15461555, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2837]], camposKey:0962-9351 2013-01-01 Mediators of Inflammation and Immune Responses in the Human Gastrointestinal Tract00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2862]], camposKey:0301-0546 2012-01-01 Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients38, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77032]], camposKey:0002-9483 2012-01-01 Detecting modular components on the human skull: implications for the structuring of global human cranial variation.9798, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49144]], camposKey:0953-6205 2012-01-01 Developing strategies to improve the quality of life of patients with gluten intolerance in patients with and without coeliac disease68, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49142]], camposKey:1078-0998 2012-01-01 Human gut-specific homeostatic dendritic cells are generated from blood precursors by the gut microenvironment12751286, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2864]], camposKey:0014-2980 2012-01-01 IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate13371353, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52754]], camposKey:1932-6203 2012-01-01 Microbiota/host crosstalk biomarkers: Regulatory response of human intestinal dendritic cells exposed to Lactobacillus extracellular encrypted peptide00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49141]], camposKey:0009-9104 2012-01-01 Skin- and gut-homing molecules on human circulating ¿¿ T cells and their dysregulation in inflammatory bowel disease122130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49143]], camposKey:0198-8859 2012-01-01 T-cell proliferation and forkhead box P3 expression in human T cells are dependent on T-cell density: Physics of a confined space?223231, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2859]], camposKey:0002-9270 2011-01-01 Are Non-Celiac Disease Gluten-Intolerant Patients Innate Immunity Responders to Gluten?22012201, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2830]], camposKey:0019-2805 2011-01-01 Intestinal homeostatic signals are lost in affected areas of ulcerative colitis patients inducing an abnormal skin homing phenotype in dendritic cells and T-cells they stimulate144144, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77033]], camposKey:0002-9483 2011-01-01 Testing evolutionary and dispersion scenarios for the settlement of the New World169169, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2828]], camposKey:0340-5354 2011-01-01 Value of tumour necrosis factor-alpha and interleukin 6 polymorphisms as prognostic marker of efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis149149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77034]], camposKey:0019-2805 2010-12-01 Monocyte-derived dendritic cells lack the expression of homing markers although retinoic acid generates functional gut-homing dendritic cells8889, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2858]], camposKey:0891-6934 2010-01-01 Altered expression of the lymphocyte activation antigen CD30 in active celiac disease288298, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49145]], camposKey:1078-0998 2010-01-01 Homing of immune cells: Role in homeostasis and intestinal inflammation19691977, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77031]], camposKey:0029-6651 2010-01-01 Hypovitaminosis D in patients on long-term parenteral nutrition00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2846]], camposKey:1351-5101 2010-01-01 Value of interleukin 1 polymorphisms as prognostic marker of efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis488488, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=18300]], camposKey:0210-6523 2009-01-01 Avances en el estudio de la enfermedad celíaca281297, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2839]], camposKey:0301-0546 2009-01-01 From autoimmune enteropathy to the IPEX (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) syndrome208215, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2855]], camposKey:0962-9351 2009-01-01 High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2871]], camposKey:0017-5749 2009-01-01 Is it true that coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa886887, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2849]], camposKey:0105-4538 2009-01-01 The profile of gliadin-degrading activity of duodenal mucosa points to a role of microflora in celiac disease366366, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2815]], camposKey:0340-5354 2008-01-01 Anti-inflammatory cytokine gene polymorphisms in multiple sclerosis: a study in a Spanish population142142, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2869]], camposKey:0277-2116 2008-01-01 Celiac disease pathogenesis: The proinflammatory cytokine network2730, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2831]], camposKey:1130-0108 2008-01-01 Changes in gen CARD15 offer a short relationship with phenotypes in Crohn's disease in the Asturias (vol 99, pg 570, 2007)740740, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3307]], camposKey:1177-3928 2008-01-01 Cytokine, chemokine and immune activation pathway profiles in celiac disease: An immune system activity screening by expression macroarrays00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2863]], camposKey:1521-6616 2008-01-01 Decreased circulating iNKT cell numbers in refractory coeliac disease172179, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2861]], camposKey:0009-9104 2008-01-01 Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients6473, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49146]], camposKey:1566-0621 2008-01-01 Spatial and temporal variation of genetic diversity and estimation of effective population sizes in Atlantic salmon (Salmo salar, L.) populations from Asturias (Northern Spain) using microsatellites807819, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2867]], camposKey:1130-0108 2007-01-01 CARD 15 mutations are poorly related to Crohn's disease phenotypes in Asturias570575, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49149]], camposKey:1130-0108 2007-01-01 CARD15 mutations are poorly related to Crohn's disease phenotypes in Asturias Las mutaciones del gen CARD15 presentan escasa relación con los fenotipos de la enfermedad de Crohn en Asturias570575, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3308]], camposKey:1139-2436 2007-01-01 CTLA4+49 polymorphism in coeliac disease: An association in heterozygosis? Polimorfismo CTLA4+49 en la enfermedad celíaca: ¿ Una asociación en heterocigosis?4952, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2847]], camposKey:0105-4538 2007-01-01 Gliadin-induced dendritic cells maturation in coeliac and non-coeliac disease individuals370370, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2856]], camposKey:0017-5749 2007-01-01 Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides889890, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2870]], camposKey:0091-6749 2007-01-01 Persistence of proinflarnmatory response after severe respiratory syncytial virus disease in children15471550, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2838]], camposKey:1148-5493 2007-01-01 Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children162167, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49147]], camposKey:0044-8486 2007-01-01 Use of microsatellites and a combinatorial optimization approach in the acquisition of gilthead seabream (Sparus aurata L.) broodstocks for hatcheries200210, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49148]], camposKey:0173-9565 2007-01-01 Usefulness of microsatellite markers developed from Pagellus bogaraveo to genetically study five different species of Sparidae184187, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49150]], camposKey:0967-4845 2006-01-01 Interleukin (IL)-1ß, IL-6 and IL-8 in nasal secretions: A common role for innate immunity in viral bronchial infection in infants?173175, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52764]], camposKey:1471-8278 2006-01-01 Isolation and characterization of polymorphic microsatellite markers in Pagellus bogaraveo, and cross-species amplification in Sparus aurata and Dicentrarchus labrax3335, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3311]], camposKey:0301-0546 2005-01-01 IL6, IL10 and TGFB1 gene polymorphisms in coeliac disease: Differences between DQ2 positive and negative patients245249][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=32551]},camposKey: 81 110 Mecanismos de la tolerancia intestinal a las proteínas de la dieta 8409041618Avances en el conocimiento de las patologías relacionadas con el gluten y evolución de los alimentos sin gluten 1 2018-01-01 Sociedad Española de Enfermedad Celíaca (SEEC) , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=27966]},camposKey: 219 246 Inmunopatogenia de la enfermedad celíaca 8416270937Enfermedad celíaca 1 2016-01-01 Ergon , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29232]},camposKey: 105 140 Mechanims of intestinal tolerance to dietary proteins 978-84-943418-2-3Advances in the Understanding of Gluten related Pathology and the Evolution of Gluten-Free Foods 1 2015-01-01 Omnia Publisher, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=18976]},camposKey: 105 139 Mechanisms of Intestinal Tolerance to Dietary Proteins 978-84-943418-2-3Advances in the Understanding of Gluten related Pathology and the Evolution of Gluten-Free Foods 1 2015-01-01 Omnia Publisher, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29749]},camposKey: 11 20 El sistema inmune del tracto digestivo y mecanismos de inflamación 8484738914Tratado de gastroenterología, hepatología y nutrición pediátrica aplicada de la SEGHNP 2 2011-01-01 Ergon , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29233]},camposKey: 177 200 Inmunopatogenia de la enfermedad celíaca 8484739589Enfermedad celíaca 1 2011-01-01 Ergon, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29234]},camposKey: 171 176 La genética de la enfermedad celíaca 8484739589Enfermedad celíaca 1 2011-01-01 Ergon][][][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64644]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63874]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64369]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64686]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64644]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63874]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64369]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64686]]][][][][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@20203054, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@768bc7c6][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8d4a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8b1c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8663, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8d0c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8c8e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f923e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8337, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f9619, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f9743, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8aa4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8222][][][][][][com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1416]]][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5bd968], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c4e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4617f0], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c20], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4662e8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5b8df1], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125b3], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460795], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412236]][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16f64, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16b87][]

PUBLICACIONES

Artículos de revista (143)

Llucia-Carol L.; Muiño E.; Cullell N.; Carcel-Marquez J.; Lledos M.; Gallego-Fabrega C.; Martin-Campos J.; Marti-Fabregas J.; Aguilera-Simon A.; Planas A.M.; DeDiego M.L.; de Felipe Mimbrera A.; Masjuan J.; Garcia-Madrona S.; Segura T.; Gonzalez-Villar E.; Serrano-Heras G.; Dominguez Mayoral A.; Menendez-Valladares P.; Montaner J.; Migeotte I.; Rahmouni S.; Darcis G.; Bernardo D.; Rojo S.; Schulte E.C.; Protzer U.; Fricke L.; Winter C.; Niemi M.E.K.; Cordioli M.; Delgado P.; Fernandez-Cadenas I. Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes . International Journal of Molecular Sciences 2023; 24(17).

Enlace a la publicación
Ver Todos

Capítulos de libros (7)

Bernardo Ordiz, David; Knight, Stella C. Mecanismos de la tolerancia intestinal a las proteínas de la dieta . En: -. Avances en el conocimiento de las patologías relacionadas con el gluten y evolución de los alimentos sin gluten. Sociedad Española de Enfermedad Celíaca (SEEC) 2018. p. 81-110.


Ver Todos
 

AYUDA A LA INVESTIGACIÓN

Proyectos (9)

CONSORCIO ESTATAL EN RED PARA EL DESARROLLO DE MEDICAMENTOS DE TERAPIAS AVANZADAS (CERTERA). Equipo Investigadores: GONZALEZ-VALLINAS GARRACHON, MARGARITA (IP); BERNARDO ORDIZ, DAVID; GIROTTI ., ALESSANDRA; ARIAS VALLEJO, FRANCISCO JAVIER; FERNANDEZ GUTIERREZ, JESUS ANTONIO; FUENTE GARCIA, MIGUEL ANGEL DE LA; NUÑEZ LLORENTE, LUCIA; GARCIA DIAZ, VERONICA; BARBADO AJO, MARIA JULIA; CARRERA AGUADO, NORA; CUBERO RIBAS, AFRICA. CERT22/00071. Entidades Participantes: UNIVERSIDAD DE VALLADOLID (UVa). Entidades Financiadoras: UNIÓN EUROPEA.-NEXT GENERATION UE, PLAN DE RECUPERACIÓN, TRANSFORMACIÓN Y RESILIENCIA, MICINN. MINISTERIO DE CIENCIA E INNOVACIÓN , INSTITUTO DE SALUD CARLOS III. 01/01/2024-30/04/2026

Next Generation-UEMnisterio de Ciencia e InnovaciónInstituto de Salud Carlos IIIPlan de Recuperación, transformación y Resiliencia
Ver Todos

Convenios/Contratos OTC (11)

ENSAYO CLÍNICO DE INTERVENCIÓN NUTRICIONAL PARA EVALUAR UN SUPLEMENTO NUTRICIONAL ORAL ESPECÍFICO SOBRE EL ESTADO NUTRICIONAL DE PACIENTES CON CANCER Y DESNUTRICIÓN SOMETIDOS A TRATAMIENTO ONCOLÓGICO ESPECÍFICO AMBULATORIO: PROYECTO ALISENOC.. Equipo Investigadores: BERNARDO ORDIZ, DAVID (IP). Entidades Participantes: FUNDACION GENERAL DE LA UNIVERSIDAD DE VALLADOLID.. Entidades Financiadoras: ADVENTIA PHARMA SL.. 06/02/2024

Ver Todos

Otras ayudas y becas (4)

CONTRATO PREDOCTORAL-AECC DE HIERRO GONZALEZ, ALEJANDRO DEL: IDENTIFICACIÓN DE BIOMARCADORES NO INVASIVOS PARA UN MANEJO PERSONALIZADO DEL CÁNCER COLORRECTAL,. BERNARDO ORDIZ, DAVID (Director). HIERRO GONZALEZ, ALEJANDRO DEL (Beneficiario). 01/06/2023 - 31/05/2026. 73.500,00 EUR.

AECC
Ver Todos
 

OTROS

Congresos (2)

ASISTENCIA AL ICMI 2022, SEATTLE ( ESTADOS UNIDOS DE AMÉRICA ) 16/07/2022 -
(Conferencia invitada). BERNARDO ORDIZ, DAVID. ASISTENCIA AL ICMI 2022
Ver Todos

Patentes (1)

EDUARDO TAMAYO GÓMEZ HUGO GONZALO BENITO; Pedro José Martínez de Paz; ESTHER GÓMEZ SÁNCHEZ; MARÍA HEREDIA RODRÍGUEZ; ALVARO TAMAYO VELASCO; ITZIAR FERNÁNDEZ MARTÍNEZ; DAVID BERNARDO ORDIZ; METHOD FOR THE DIAGNOSIS OF A CORONAVIRUS INFECTION. EP21382219.0. 2021
Ver Todos

Proyectos de innovación docente (2)

El Gran Inmunoescape - PID2022/31. Universidad de Valladolid. 01/09/2022.
Ver Todos
Cargando información ...
Universidad de Valladolid - Copyright Universidad de Valladolid - Todos los derechos reservados